How to appeal a Premera Blue Cross substance use disorder treatment (sud/moud) denial

The framework that applies to your appeal

Federal law gives you the right to a full and fair internal appeal, then an external review by an independent third party.

Premera Blue Cross-specific note: BCBS licensee for Washington and Alaska (~2.4M members). Express Scripts PBM. WA OIC oversight. WA has strong mental health parity enforcement and surprise-billing protections that pre-date federal NSA.

What Premera Blue Cross's policy requires for substance use disorder treatment (sud/moud)

Cited policy: Anthem clinical guideline (SUD Treatment) + BCBS plan-specific MAT policies

ASAM-referenced. ACA EHB compliance for SUD. BlueCard residential criteria.

How Premera Blue Cross denies substance use disorder treatment (sud/moud) — and how to counter it

Where Premera Blue Cross pushes back: 1) Residential 3.5/3.7 denied — 'lower LOC adequate'; 2) LOS denial at concurrent review (typically 14 days); 3) Methadone OTP coverage gaps in commercial plans.

Counter-arguments that hold up: CG-BEH-04 explicitly references ASAM Criteria — cite payer's own policy + ASAM 4e dimensions. ACA EHB §1302(b)(1)(E) — SUD is essential benefit; commercial methadone exclusion likely violates EHB and parity. Wit v. UBH (9th Cir. 2023) re LOC criteria deviating from generally accepted standards — precedent applies to non-GASC criteria.

What Premera Blue Cross typically denies for substance use disorder treatment (sud/moud)

Across Premera Blue Cross's commercial and Medicare books, denials cluster around a small number of patterns. For substance use disorder treatment (sud/moud), expect:

• WA-specific mental health parity violations
• Step therapy via Express Scripts
• Out-of-network reductions
• Specialty drug prior auth

Treatments most often denied in this category

These are the substance use disorder treatment (sud/moud) treatments most often flagged for prior auth, step therapy, or medical necessity review:

• Suboxone (subli)
• Sublocade LA
• Brixadi LA
• Methadone OTP
• Vivitrol LA
• Naltrexone PO

How to submit the appeal to Premera Blue Cross

1. Read the denial letter — note the exact denial reason code and the appeal deadline (180 days from the date on the letter).
2. Gather supporting documentation: physician letter of medical necessity, relevant clinical notes, peer-reviewed citations supporting the treatment for your indication, and the policy or coverage document Premera Blue Cross cited in the denial.
3. File the appeal through Premera Blue Cross's portal (members: https://www.premera.com ; providers: https://www.premera.com/wa/provider). Standard decision returns within 30 days; expedited urgent appeals return within 72 hours.
4. If denied again, request external review by an independent reviewer within 4 months of the final internal denial. In WA, the state insurance department coordinates external review for fully-insured plans; ERISA self-funded plans use a federal external review through DOL/EBSA.

Clinician or prior-auth team handling this on the practice side? See Premera Blue Cross's prior-authorization criteria by drug: Premera Blue Cross PA criteria on ApprovalHelp.